Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Gallbladder Neoplasms × Electroporation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 8 Liver Neoplasms 4 Carcinoma, Hepatocellular 4 Lung Neoplasms 3 Squamous Intraepithelial Lesions 2 Prostatic Neoplasms 2 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Unresectable Pancreatic Cancer 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Rectal Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Neoplasm Metastasis 1 Melanoma 1 Lymphatic Metastasis 1 Liver, Cancer of, Non-Resectable 1 Laryngeal Neoplasms 1 Head and Neck Neoplasms 1 HIV Seropositivity 1 Gallbladder Neoplasms 1 Extremities Neoplasms 1 Esophageal Neoplasms 1 Colorectal Liver Metastases 1 Carcinoma, Renal Cell 1 Advanced Intestinal Cancer 1

Interventions

Gemcitabine 30 Cisplatin 20 Capecitabine 17 Oxaliplatin 14 Leucovorin 10 Fluorouracil 10 Irinotecan 8 Erlotinib Hydrochloride 7 pembrolizumab 5 Bevacizumab 5 Radiotherapy 4 Carboplatin 4 Watchful Waiting 3 Immunohistochemistry 3 Docetaxel 3 Albumin-Bound Paclitaxel 3 130-nm albumin-bound paclitaxel 3 trifluridine tipiracil drug combination 2 tremelimumab 2 regorafenib 2 durvalumab 2 dehydroftorafur 2 Trastuzumab 2 Taxes 2 Sorafenib 2 Platinum 2 Paclitaxel 2 Interleukin-12 Subunit p35 2 Epirubicin 2 Cyclophosphamide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02430662 2021-09-05

IRE

Fuda Cancer Hospital, Guangzhou

Phase NA Completed

Gastrointestinal

Gallbladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡